Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma
Update your browser to view ScienceDirect.
View recommended browsers.
Request details:
Request ID: 8929b52decdb1643-SJC
IP: 116.62.10.13
UTC time: 2024-06-12T12:05:12+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4
留言 (0)